Legal Representation
Attorney
STEPHANIE K WADE
USPTO Deadlines
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 3, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Mar 29, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 29, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 15, 2005 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Jun 15, 2005 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Jun 15, 2005 | EXT5 | S | EXTENSION 5 FILED | Loading... |
| Jun 15, 2005 | EX5G | S | EXTENSION 5 GRANTED | Loading... |
| Dec 13, 2004 | EX4G | S | EXTENSION 4 GRANTED | Loading... |
| Nov 19, 2004 | I | PAPER RECEIVED | Loading... | |
| Nov 19, 2004 | EXT4 | S | EXTENSION 4 FILED | Loading... |
| Jun 9, 2004 | EX3G | S | EXTENSION 3 GRANTED | Loading... |
| May 27, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| May 18, 2004 | I | PAPER RECEIVED | Loading... | |
| May 18, 2004 | EXT3 | S | EXTENSION 3 FILED | Loading... |
| Feb 5, 2004 | EX2G | S | EXTENSION 2 GRANTED | Loading... |
| Jan 9, 2004 | I | PAPER RECEIVED | Loading... | |
| Jan 9, 2004 | EXT2 | S | EXTENSION 2 FILED | Loading... |
| Sep 8, 2003 | I | PAPER RECEIVED | Loading... | |
| Aug 13, 2003 | EX1G | S | EXTENSION 1 GRANTED | Loading... |
| Jul 21, 2003 | I | PAPER RECEIVED | Loading... | |
| Jul 21, 2003 | EXT1 | S | EXTENSION 1 FILED | Loading... |
| Jan 21, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 29, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 9, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Aug 12, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 5, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammations and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005